Washington, District of Columbia, United States Perseus is the famous VC, which was founded in 1995. The main department of described VC is located in the Washington. The company was established in North America in United States.
Opposing the other organizations, this Perseus works on 8 percentage points less the average amount of lead investments. The usual things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2007. The top amount of exits for fund were in 2007. Considering the real fund results, this VC is 18 percentage points more often commits exit comparing to other organizations. The fund is constantly included in less than 2 investment rounds annually.
Among the most successful fund investment fields, there are Manufacturing, Biopharma. Among the various public portfolio startups of the fund, we may underline Vehicle Production Group, CeNeRx BioPharma, Cymbet For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has specific favorite in a number of founders of portfolio startups. Besides, a startup needs to be aged 6-10 years to get the investment from the fund.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Perseus, startups are often financed by Ventures West, Oregon Life Sciences, Nth Power. The meaningful sponsors for the fund in investment in the same round are Ventures West, Oregon Life Sciences, Nth Power. In the next rounds fund is usually obtained by Ventures West, Oregon Life Sciences, Nth Power.
Besides them, we counted 5 critical employees of this fund in our database.
Related Funds
Funds with similar focus
| Fund Name | Location |
| AKM Solutions | Karachi, Pakistan, Sindh |
| Aqua Fund | - |
| Bayerische Motoren Werke | Bayern, Germany, Munich |
| Caesarea Medical Electronics | Caesarea, Hefa, Israel |
| Camber Capital Corp | Boston, Massachusetts, United States |
| CanopyBoulder | Boulder, Colorado, United States |
| De-Carceration Fund | Pennsylvania, Radnor, United States |
| Hanmi Venture Capital | Seoul, Seoul-t'ukpyolsi, South Korea |
| Innfond | - |
| JH Partners | California, San Francisco, United States |
| Jiade Touzi | - |
| Mentor Graphics | Oregon, United States, Wilsonville |
| Naray Mobile Telecom | Seoul, Seoul-t'ukpyolsi, South Korea |
| Net-Partners | Belgium, Brussels, Brussels Hoofdstedelijk Gewest |
| Numoda Capital Innovations | Pennsylvania, Philadelphia, United States |
| QCP Capital | Central Region, Singapore, Singapore |
| ServiceNow founding members | - |
| Shapeways | New York, New York, United States |
Discover 4 more decision makers Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
BlueWillow Biologics | $11M | 28 Nov 2012 | Ann Arbor, Michigan, United States | ||
| $13M | 13 Aug 2010 | Cary, North Carolina, United States | |||
Cymbet | $31M | 25 Jan 2010 | Minnesota, United States | ||
BlueWillow Biologics | $10M | 08 Jul 2009 | Ann Arbor, Michigan, United States | ||
BlueWillow Biologics | $12M | 18 Feb 2009 | Ann Arbor, Michigan, United States | ||
Ascenta Therapeutics | $50M | 10 Apr 2007 | Pennsylvania, United States | ||
BlueWillow Biologics | $30M | 21 Oct 2006 | Ann Arbor, Michigan, United States | ||
MAP Pharmaceuticals | $25M | 31 Jan 2006 | Mountain View, California, United States | ||
Iridian Technologies | $5M | 11 Apr 2005 | New Jersey, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
BlueWillow Biologics | $11M | 28 Nov 2012 | Ann Arbor, Michigan, United States | ||
| $13M | 13 Aug 2010 | Cary, North Carolina, United States | |||
Cymbet | $31M | 25 Jan 2010 | Minnesota, United States | ||
BlueWillow Biologics | $10M | 08 Jul 2009 | Ann Arbor, Michigan, United States | ||
BlueWillow Biologics | $12M | 18 Feb 2009 | Ann Arbor, Michigan, United States | ||
Ascenta Therapeutics | $50M | 10 Apr 2007 | Pennsylvania, United States | ||
BlueWillow Biologics | $30M | 21 Oct 2006 | Ann Arbor, Michigan, United States | ||
MAP Pharmaceuticals | $25M | 31 Jan 2006 | Mountain View, California, United States | ||
Iridian Technologies | $5M | 11 Apr 2005 | New Jersey, United States |
